Financials Humedix Co., Ltd.

Equities

A200670

KR7200670008

Pharmaceuticals

End-of-day quote Korea S.E. 18:00:00 2024-05-16 EDT 5-day change 1st Jan Change
33,950 KRW +2.72% Intraday chart for Humedix Co., Ltd. -4.10% +0.59%

Valuation

Fiscal Period: December 2020 2021 2022 2023 2024
Capitalization 1 225,466 225,208 252,646 352,385 352,385
Enterprise Value (EV) 1 225,443 225,178 252,646 352,385 352,385
P/E ratio 15 x 19.6 x 12.2 x 13 x 9.6 x
Yield 1.68% 1.67% - 1.77% 1.77%
Capitalization / Revenue 2.29 x 2.03 x - 2.29 x 1.97 x
EV / Revenue 2.29 x 2.03 x - 2.29 x 1.97 x
EV / EBITDA 8.41 x 8.15 x - 7.05 x 5.87 x
EV / FCF 37.1 x 41.4 x - 11 x 9.79 x
FCF Yield 2.69% 2.42% - 9.08% 10.2%
Price to Book 1.88 x 1.79 x - 2.02 x 1.47 x
Nbr of stocks (in thousands) 9,493 9,403 9,121 10,380 10,380
Reference price 2 23,750 23,950 27,700 33,950 33,950
Announcement Date 21-02-15 22-02-07 23-03-22 - -
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024
Net sales 1 98.48 111 - 154 179
EBITDA 1 26.8 27.64 - 50 60
EBIT 1 16.64 15.99 - 40.2 47.3
Operating Margin 16.9% 14.41% - 26.1% 26.42%
Earnings before Tax (EBT) 1 20.31 11.34 - 36.6 51.6
Net income 1 15.08 9.363 21.09 29.3 39.7
Net margin 15.32% 8.44% - 19.03% 22.17%
EPS 2 1,587 1,224 2,274 2,607 3,537
Free Cash Flow 3 6,070 5,441 - 32,000 36,000
FCF margin 6,163.92% 4,902.38% - 20,779.22% 20,106.12%
FCF Conversion (EBITDA) 22,651.18% 19,683.42% - 64,000% 60,000%
FCF Conversion (Net income) 40,243% 58,117.61% - 109,215.02% 90,680.1%
Dividend per Share 2 400.0 400.0 - 600.0 600.0
Announcement Date 21-02-15 22-02-07 23-03-22 - -
1KRW in Billions2KRW3KRW in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024
Net Debt - - - - -
Net Cash position 23.2 29.6 - - -
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow 1 6,070 5,441 - 32,000 36,000
ROE (net income / shareholders' equity) 13% 7.38% - 19.5% 18.5%
ROA (Net income/ Total Assets) 9.61% 4.77% - 13.3% 16.7%
Assets 2 157 196.2 - 220.3 237.7
Book Value Per Share 3 12,633 13,399 - 16,828 23,069
Cash Flow per Share 3 - 1,935 - 3,449 4,518
Capex 2 17.7 13.7 - 2 10
Capex / Sales 17.96% 12.38% - 1.3% 5.59%
Announcement Date 21-02-15 22-02-07 23-03-22 - -
1KRW in Million2KRW in Billions3KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
33,950 KRW
Average target price
56,000 KRW
Spread / Average Target
+64.95%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A200670 Stock
  4. Financials Humedix Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW